Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers

NCT07207291 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Infections
Urinary Tract Infections
Intra-Abdominal Infections
Respiratory Tract Infections

Interventions

DRUG: JKN2501
DRUG: Placebo

Sponsor

Joincare Pharmaceutical Group Industry Co., Ltd